Circular RNAs as the pivotal regulators of epithelial-mesenchymal transition in gastrointestinal tumor cells
- PMID: 37087995
- DOI: 10.1016/j.prp.2023.154472
Circular RNAs as the pivotal regulators of epithelial-mesenchymal transition in gastrointestinal tumor cells
Abstract
Gastrointestinal (GI) cancers, as the most common human malignancies are always considered one of the most important health challenges in the world. Late diagnosis in advanced tumor stages is one of the main reasons for the high mortality rate and treatment failure in these patients. Therefore, investigating the molecular pathways involved in GI tumor progression is required to introduce the efficient markers for the early tumor diagnosis. Epithelial-mesenchymal transition (EMT) is one of the main cellular mechanisms involved in the GI tumor metastasis. Non-coding RNAs (ncRNAs) are one of the main regulatory factors in EMT process. Circular RNAs (circRNAs) are a group of covalently closed loop ncRNAs that have higher stability in body fluids compared with other ncRNAs. Considering the importance of circRNAs in regulation of EMT process, in the present review we discussed the role of circRNAs in EMT process during GI tumor invasion. It has been reported that circRNAs mainly affect the EMT process through the regulation of EMT-specific transcription factors and signaling pathways such as WNT, PI3K/AKT, TGF-β, and MAPK. This review can be an effective step in introducing a circRNA/EMT based diagnostic panel marker for the early tumor detection among GI cancer patients.
Keywords: Circular RNAs; Early detection; Epithelial-mesenchymal transition; Gastrointestinal cancers; Non-coding RNAs; Non-invasive.
Copyright © 2023 Elsevier GmbH. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest None.
Similar articles
-
Biological roles and molecular mechanism of circular RNAs in epithelial-mesenchymal transition of gastrointestinal malignancies.Oncol Res. 2025 Feb 28;33(3):549-566. doi: 10.32604/or.2024.051589. eCollection 2025. Oncol Res. 2025. PMID: 40109856 Free PMC article. Review.
-
Functional roles of circular RNAs during epithelial-to-mesenchymal transition.Mol Cancer. 2019 Sep 16;18(1):138. doi: 10.1186/s12943-019-1071-6. Mol Cancer. 2019. PMID: 31526370 Free PMC article. Review.
-
Circular RNAs: Emerging regulators of signaling pathways in epithelial-mesenchymal transition and angiogenesis during breast cancer progression.Semin Oncol. 2025 Apr;52(2):152340. doi: 10.1016/j.seminoncol.2025.152340. Epub 2025 Apr 11. Semin Oncol. 2025. PMID: 40220369 Review.
-
Circular RNAs in EMT-driven metastasis regulation: modulation of cancer cell plasticity, tumorigenesis and therapy resistance.Cell Mol Life Sci. 2024 May 11;81(1):214. doi: 10.1007/s00018-024-05236-w. Cell Mol Life Sci. 2024. PMID: 38733529 Free PMC article. Review.
-
Screening and identification of epithelial-to-mesenchymal transition-related circRNA and miRNA in prostate cancer.Pathol Res Pract. 2020 Feb;216(2):152784. doi: 10.1016/j.prp.2019.152784. Epub 2019 Dec 19. Pathol Res Pract. 2020. PMID: 31882179
Cited by
-
CircRNAs: Pivotal modulators of TGF-β signalling in cancer pathogenesis.Noncoding RNA Res. 2024 Jan 26;9(2):277-287. doi: 10.1016/j.ncrna.2024.01.013. eCollection 2024 Jun. Noncoding RNA Res. 2024. PMID: 38505309 Free PMC article. Review.
-
Role of microRNA-363 during tumor progression and invasion.J Physiol Biochem. 2024 Aug;80(3):481-499. doi: 10.1007/s13105-024-01022-1. Epub 2024 May 1. J Physiol Biochem. 2024. PMID: 38691273 Review.
-
An aptamer and Au/Si CCA based SERS sensor for ultra-sensitive detection of Vimentin during EMT in gastric cancer.Front Bioeng Biotechnol. 2023 Dec 7;11:1310258. doi: 10.3389/fbioe.2023.1310258. eCollection 2023. Front Bioeng Biotechnol. 2023. PMID: 38130825 Free PMC article.
-
MicroRNAs as the pivotal regulators of Temozolomide resistance in glioblastoma.Mol Brain. 2024 Jul 2;17(1):42. doi: 10.1186/s13041-024-01113-6. Mol Brain. 2024. PMID: 38956588 Free PMC article. Review.
-
MicroRNA-98 as a novel diagnostic marker and therapeutic target in cancer patients.Discov Oncol. 2024 Aug 29;15(1):385. doi: 10.1007/s12672-024-01270-z. Discov Oncol. 2024. PMID: 39210158 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources